GENI vs. DIS, AMC, LION, SPHR, GVC, SONG, TKO, NFC, MCS, and RDI
Should you be buying GENinCode stock or one of its competitors? The main competitors of GENinCode include Distil (DIS), Amur Minerals (AMC), Lionsgold (LION), Sphere Medical (SPHR), Entain PLC (GVC.L) (GVC), Hipgnosis Songs (SONG), Taseko Mines (TKO), Next Fifteen Communications Group (NFC), McCarthy & Stone (MCS), and Rdi Reit (RDI). These companies are all part of the "entertainment" industry.
GENinCode vs.
GENinCode (LON:GENI) and Distil (LON:DIS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, community ranking, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.
Distil received 39 more outperform votes than GENinCode when rated by MarketBeat users.
In the previous week, GENinCode's average media sentiment score of 0.00 equaled Distil'saverage media sentiment score.
47.6% of GENinCode shares are held by institutional investors. Comparatively, 0.0% of Distil shares are held by institutional investors. 39.8% of GENinCode shares are held by company insiders. Comparatively, 60.2% of Distil shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
GENinCode has a beta of 0.66, meaning that its share price is 34% less volatile than the S&P 500. Comparatively, Distil has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500.
Distil has lower revenue, but higher earnings than GENinCode. Distil is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks.
Distil has a net margin of -109.66% compared to GENinCode's net margin of -228.70%. Distil's return on equity of -22.94% beat GENinCode's return on equity.
Summary
Distil beats GENinCode on 7 of the 12 factors compared between the two stocks.
Get GENinCode News Delivered to You Automatically
Sign up to receive the latest news and ratings for GENI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
GENinCode Competitors List
Related Companies and Tools
This page (LON:GENI) was last updated on 5/2/2025 by MarketBeat.com Staff
